ClinicalTrials.Veeva

Menu

Combined Behavioral and Analgesic Trial for Fibromyalgia (COMBAT-FM)

University of Washington logo

University of Washington

Status and phase

Completed
Phase 3

Conditions

Fibromyalgia

Treatments

Drug: Tramadol
Behavioral: Cognitive Behavior Therapy for FM
Drug: Placebo
Behavioral: Health Education

Study type

Interventional

Funder types

Other

Identifiers

NCT01598753
STUDY00001259

Details and patient eligibility

About

This is a randomized control study that involves a combination of a drug treatment, behavioral health, and placebo controls.

Some participants will receive a medication approved by the Food and Drug Administration for treatment of moderate to moderately severe pain called Tramadol HC1 IR. Others will receive an inactive pill, called a placebo. There will also be 2 different types of behavioral health treatments, Cognitive-Behavior Therapy (CBT) and Health Education (HE) both of which have been recommended for the treatment of patients with FM by the American Pain Society.

There are 4 possible study treatment combinations:

  1. Tramadol + CBT,
  2. Tramadol + HE,
  3. Placebo + CBT,
  4. Placebo + HE.

Although Tramadol, CBT, and HE have been shown to have some benefits for FM patients, there have been no studies that have evaluated the combination of medication and a behavioral health treatment. The primary purpose of this study is to compare the benefits of the 4 combinations listed.

Enrollment

134 patients

Sex

All

Ages

21 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Males and Females 21-70
  • Diagnosis of Fibromyalgia
  • Current primary care physician
  • Fluent in English

Exclusion criteria

  • Rheumatologic disorders
  • Drug and alcohol abuse in the past year
  • Psychiatric hospitalization in the past 6 months
  • Current use of Tramadol
  • Certain antidepressant and other pain medications

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Quadruple Blind

134 participants in 4 patient groups, including a placebo group

Tramadol
Active Comparator group
Treatment:
Drug: Tramadol
Placebo
Placebo Comparator group
Treatment:
Drug: Placebo
Cognitive Behavior Therapy for FM
Active Comparator group
Treatment:
Behavioral: Cognitive Behavior Therapy for FM
Health Education
Sham Comparator group
Treatment:
Behavioral: Health Education

Trial documents
1

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems